California facility loses mammography accreditation following quality issues

A California-based radiology center has stopped screening women for breast cancer after a review found quality problems with its mammography images.

The American College of Radiology revoked Radiology Disc of Encino’s accreditation after it did not pass a mandatory inspection under the Mammography Quality Standards Act. The Encino, California-based center failed to adhere to image quality standards in 21 of its 30 breast screening exams.

According to a report from the Food and Drug Administration, mammography performed at Radiology Disc of Encino is a “serious risk to human health,” and directed the institution to notify all patients who may have been endangered.

As of Dec. 18, Radiology Disc has met all of the FDA’s requirements. The facility is no longer performing mammography, according to the government agency.

Earlier this month, the FDA released a similar announcement related to a Raleigh-North Carolina-based radiology practice that was forced to stop mammography screening due to problems with its quality of images.

The Adverse Event and Action reports are mandated under the Mammography Quality Standards Act. These annual reports are put together by the FDA to notify the general public and physicians of adverse actions taken against mammography facilities.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.